The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Bioactive Proteins and Peptides Market Research Report 2025
Synopsis
The global market for Bioactive Proteins and Peptides was valued at US$ 291 million in the year 2024 and is projected to reach a revised size of US$ 618 million by 2031, growing at a CAGR of 11.5% during the forecast period.
Bioactive peptides are a group of biological molecules that are normally buried in the structure of parent proteins and become active after the cleavage of the proteins. Another group of peptides is actively produced and found in many microorganisms and the body of organisms. Today, many groups of bioactive peptides have been marketed chemically or recombinantly.
North American market for Bioactive Proteins and Peptides is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Bioactive Proteins and Peptides is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Bioactive Proteins and Peptides include Nuritas, Gelita, Arta Peptidion, Seagarden, Phermpep, Hubei Reborn Biotech, Tus-Harvest Biotech, Zhejiang Huitai Life Health Technology, Beijing Renxinruoshui Biotech, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Bioactive Proteins and Peptides, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bioactive Proteins and Peptides.
The Bioactive Proteins and Peptides market size, estimations, and forecasts are provided in terms of output/shipments (Tons) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Bioactive Proteins and Peptides market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Bioactive Proteins and Peptides manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Nuritas
Gelita
Arta Peptidion
Seagarden
Phermpep
Hubei Reborn Biotech
Tus-Harvest Biotech
Zhejiang Huitai Life Health Technology
Beijing Renxinruoshui Biotech
by Type
Plant Source
Animal Source
by Application
Food
Pharmaceutical
Cosmetic
Others
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Rest of Europe
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Bioactive Proteins and Peptides manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Bioactive Proteins and Peptides by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Bioactive Proteins and Peptides in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
The global market for Bioactive Proteins and Peptides was valued at US$ 291 million in the year 2024 and is projected to reach a revised size of US$ 618 million by 2031, growing at a CAGR of 11.5% during the forecast period.
Bioactive peptides are a group of biological molecules that are normally buried in the structure of parent proteins and become active after the cleavage of the proteins. Another group of peptides is actively produced and found in many microorganisms and the body of organisms. Today, many groups of bioactive peptides have been marketed chemically or recombinantly.
North American market for Bioactive Proteins and Peptides is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Bioactive Proteins and Peptides is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Bioactive Proteins and Peptides include Nuritas, Gelita, Arta Peptidion, Seagarden, Phermpep, Hubei Reborn Biotech, Tus-Harvest Biotech, Zhejiang Huitai Life Health Technology, Beijing Renxinruoshui Biotech, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Bioactive Proteins and Peptides, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bioactive Proteins and Peptides.
The Bioactive Proteins and Peptides market size, estimations, and forecasts are provided in terms of output/shipments (Tons) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Bioactive Proteins and Peptides market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Bioactive Proteins and Peptides manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Nuritas
Gelita
Arta Peptidion
Seagarden
Phermpep
Hubei Reborn Biotech
Tus-Harvest Biotech
Zhejiang Huitai Life Health Technology
Beijing Renxinruoshui Biotech
by Type
Plant Source
Animal Source
by Application
Food
Pharmaceutical
Cosmetic
Others
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Rest of Europe
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Bioactive Proteins and Peptides manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Bioactive Proteins and Peptides by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Bioactive Proteins and Peptides in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
Index1 Bioactive Proteins and Peptides Market Overview
1.1 Product Definition
1.2 Bioactive Proteins and Peptides by Type
1.2.1 Global Bioactive Proteins and Peptides Market Value Growth Rate Analysis by Type: 2024 VS 2031
1.2.2 Plant Source
1.2.3 Animal Source
1.3 Bioactive Proteins and Peptides by Application
1.3.1 Global Bioactive Proteins and Peptides Market Value Growth Rate Analysis by Application: 2024 VS 2031
1.3.2 Food
1.3.3 Pharmaceutical
1.3.4 Cosmetic
1.3.5 Others
1.4 Global Market Growth Prospects
1.4.1 Global Bioactive Proteins and Peptides Production Value Estimates and Forecasts (2020-2031)
1.4.2 Global Bioactive Proteins and Peptides Production Capacity Estimates and Forecasts (2020-2031)
1.4.3 Global Bioactive Proteins and Peptides Production Estimates and Forecasts (2020-2031)
1.4.4 Global Bioactive Proteins and Peptides Market Average Price Estimates and Forecasts (2020-2031)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Bioactive Proteins and Peptides Production Market Share by Manufacturers (2020-2025)
2.2 Global Bioactive Proteins and Peptides Production Value Market Share by Manufacturers (2020-2025)
2.3 Global Key Players of Bioactive Proteins and Peptides, Industry Ranking, 2023 VS 2024
2.4 Global Bioactive Proteins and Peptides Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.5 Global Bioactive Proteins and Peptides Average Price by Manufacturers (2020-2025)
2.6 Global Key Manufacturers of Bioactive Proteins and Peptides, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Bioactive Proteins and Peptides, Product Offered and Application
2.8 Global Key Manufacturers of Bioactive Proteins and Peptides, Date of Enter into This Industry
2.9 Bioactive Proteins and Peptides Market Competitive Situation and Trends
2.9.1 Bioactive Proteins and Peptides Market Concentration Rate
2.9.2 Global 5 and 10 Largest Bioactive Proteins and Peptides Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Bioactive Proteins and Peptides Production by Region
3.1 Global Bioactive Proteins and Peptides Production Value Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.2 Global Bioactive Proteins and Peptides Production Value by Region (2020-2031)
3.2.1 Global Bioactive Proteins and Peptides Production Value by Region (2020-2025)
3.2.2 Global Forecasted Production Value of Bioactive Proteins and Peptides by Region (2026-2031)
3.3 Global Bioactive Proteins and Peptides Production Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.4 Global Bioactive Proteins and Peptides Production Volume by Region (2020-2031)
3.4.1 Global Bioactive Proteins and Peptides Production by Region (2020-2025)
3.4.2 Global Forecasted Production of Bioactive Proteins and Peptides by Region (2026-2031)
3.5 Global Bioactive Proteins and Peptides Market Price Analysis by Region (2020-2025)
3.6 Global Bioactive Proteins and Peptides Production and Value, Year-over-Year Growth
3.6.1 North America Bioactive Proteins and Peptides Production Value Estimates and Forecasts (2020-2031)
3.6.2 Europe Bioactive Proteins and Peptides Production Value Estimates and Forecasts (2020-2031)
3.6.3 China Bioactive Proteins and Peptides Production Value Estimates and Forecasts (2020-2031)
3.6.4 Japan Bioactive Proteins and Peptides Production Value Estimates and Forecasts (2020-2031)
4 Bioactive Proteins and Peptides Consumption by Region
4.1 Global Bioactive Proteins and Peptides Consumption Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
4.2 Global Bioactive Proteins and Peptides Consumption by Region (2020-2031)
4.2.1 Global Bioactive Proteins and Peptides Consumption by Region (2020-2025)
4.2.2 Global Bioactive Proteins and Peptides Forecasted Consumption by Region (2026-2031)
4.3 North America
4.3.1 North America Bioactive Proteins and Peptides Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.3.2 North America Bioactive Proteins and Peptides Consumption by Country (2020-2031)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Bioactive Proteins and Peptides Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.4.2 Europe Bioactive Proteins and Peptides Consumption by Country (2020-2031)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Bioactive Proteins and Peptides Consumption Growth Rate by Region: 2020 VS 2024 VS 2031
4.5.2 Asia Pacific Bioactive Proteins and Peptides Consumption by Region (2020-2031)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Bioactive Proteins and Peptides Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.6.2 Latin America, Middle East & Africa Bioactive Proteins and Peptides Consumption by Country (2020-2031)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
4.6.6 GCC Countries
5 Segment by Type
5.1 Global Bioactive Proteins and Peptides Production by Type (2020-2031)
5.1.1 Global Bioactive Proteins and Peptides Production by Type (2020-2025)
5.1.2 Global Bioactive Proteins and Peptides Production by Type (2026-2031)
5.1.3 Global Bioactive Proteins and Peptides Production Market Share by Type (2020-2031)
5.2 Global Bioactive Proteins and Peptides Production Value by Type (2020-2031)
5.2.1 Global Bioactive Proteins and Peptides Production Value by Type (2020-2025)
5.2.2 Global Bioactive Proteins and Peptides Production Value by Type (2026-2031)
5.2.3 Global Bioactive Proteins and Peptides Production Value Market Share by Type (2020-2031)
5.3 Global Bioactive Proteins and Peptides Price by Type (2020-2031)
6 Segment by Application
6.1 Global Bioactive Proteins and Peptides Production by Application (2020-2031)
6.1.1 Global Bioactive Proteins and Peptides Production by Application (2020-2025)
6.1.2 Global Bioactive Proteins and Peptides Production by Application (2026-2031)
6.1.3 Global Bioactive Proteins and Peptides Production Market Share by Application (2020-2031)
6.2 Global Bioactive Proteins and Peptides Production Value by Application (2020-2031)
6.2.1 Global Bioactive Proteins and Peptides Production Value by Application (2020-2025)
6.2.2 Global Bioactive Proteins and Peptides Production Value by Application (2026-2031)
6.2.3 Global Bioactive Proteins and Peptides Production Value Market Share by Application (2020-2031)
6.3 Global Bioactive Proteins and Peptides Price by Application (2020-2031)
7 Key Companies Profiled
7.1 Nuritas
7.1.1 Nuritas Bioactive Proteins and Peptides Company Information
7.1.2 Nuritas Bioactive Proteins and Peptides Product Portfolio
7.1.3 Nuritas Bioactive Proteins and Peptides Production, Value, Price and Gross Margin (2020-2025)
7.1.4 Nuritas Main Business and Markets Served
7.1.5 Nuritas Recent Developments/Updates
7.2 Gelita
7.2.1 Gelita Bioactive Proteins and Peptides Company Information
7.2.2 Gelita Bioactive Proteins and Peptides Product Portfolio
7.2.3 Gelita Bioactive Proteins and Peptides Production, Value, Price and Gross Margin (2020-2025)
7.2.4 Gelita Main Business and Markets Served
7.2.5 Gelita Recent Developments/Updates
7.3 Arta Peptidion
7.3.1 Arta Peptidion Bioactive Proteins and Peptides Company Information
7.3.2 Arta Peptidion Bioactive Proteins and Peptides Product Portfolio
7.3.3 Arta Peptidion Bioactive Proteins and Peptides Production, Value, Price and Gross Margin (2020-2025)
7.3.4 Arta Peptidion Main Business and Markets Served
7.3.5 Arta Peptidion Recent Developments/Updates
7.4 Seagarden
7.4.1 Seagarden Bioactive Proteins and Peptides Company Information
7.4.2 Seagarden Bioactive Proteins and Peptides Product Portfolio
7.4.3 Seagarden Bioactive Proteins and Peptides Production, Value, Price and Gross Margin (2020-2025)
7.4.4 Seagarden Main Business and Markets Served
7.4.5 Seagarden Recent Developments/Updates
7.5 Phermpep
7.5.1 Phermpep Bioactive Proteins and Peptides Company Information
7.5.2 Phermpep Bioactive Proteins and Peptides Product Portfolio
7.5.3 Phermpep Bioactive Proteins and Peptides Production, Value, Price and Gross Margin (2020-2025)
7.5.4 Phermpep Main Business and Markets Served
7.5.5 Phermpep Recent Developments/Updates
7.6 Hubei Reborn Biotech
7.6.1 Hubei Reborn Biotech Bioactive Proteins and Peptides Company Information
7.6.2 Hubei Reborn Biotech Bioactive Proteins and Peptides Product Portfolio
7.6.3 Hubei Reborn Biotech Bioactive Proteins and Peptides Production, Value, Price and Gross Margin (2020-2025)
7.6.4 Hubei Reborn Biotech Main Business and Markets Served
7.6.5 Hubei Reborn Biotech Recent Developments/Updates
7.7 Tus-Harvest Biotech
7.7.1 Tus-Harvest Biotech Bioactive Proteins and Peptides Company Information
7.7.2 Tus-Harvest Biotech Bioactive Proteins and Peptides Product Portfolio
7.7.3 Tus-Harvest Biotech Bioactive Proteins and Peptides Production, Value, Price and Gross Margin (2020-2025)
7.7.4 Tus-Harvest Biotech Main Business and Markets Served
7.7.5 Tus-Harvest Biotech Recent Developments/Updates
7.8 Zhejiang Huitai Life Health Technology
7.8.1 Zhejiang Huitai Life Health Technology Bioactive Proteins and Peptides Company Information
7.8.2 Zhejiang Huitai Life Health Technology Bioactive Proteins and Peptides Product Portfolio
7.8.3 Zhejiang Huitai Life Health Technology Bioactive Proteins and Peptides Production, Value, Price and Gross Margin (2020-2025)
7.8.4 Zhejiang Huitai Life Health Technology Main Business and Markets Served
7.8.5 Zhejiang Huitai Life Health Technology Recent Developments/Updates
7.9 Beijing Renxinruoshui Biotech
7.9.1 Beijing Renxinruoshui Biotech Bioactive Proteins and Peptides Company Information
7.9.2 Beijing Renxinruoshui Biotech Bioactive Proteins and Peptides Product Portfolio
7.9.3 Beijing Renxinruoshui Biotech Bioactive Proteins and Peptides Production, Value, Price and Gross Margin (2020-2025)
7.9.4 Beijing Renxinruoshui Biotech Main Business and Markets Served
7.9.5 Beijing Renxinruoshui Biotech Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Bioactive Proteins and Peptides Industry Chain Analysis
8.2 Bioactive Proteins and Peptides Raw Material Supply Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Bioactive Proteins and Peptides Production Mode & Process Analysis
8.4 Bioactive Proteins and Peptides Sales and Marketing
8.4.1 Bioactive Proteins and Peptides Sales Channels
8.4.2 Bioactive Proteins and Peptides Distributors
8.5 Bioactive Proteins and Peptides Customer Analysis
9 Bioactive Proteins and Peptides Market Dynamics
9.1 Bioactive Proteins and Peptides Industry Trends
9.2 Bioactive Proteins and Peptides Market Drivers
9.3 Bioactive Proteins and Peptides Market Challenges
9.4 Bioactive Proteins and Peptides Market Restraints
10 Research Findings and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
List of TablesList of Tables
Table 1. Global Bioactive Proteins and Peptides Market Value by Type, (US$ Million) & (2024 VS 2031)
Table 2. Global Bioactive Proteins and Peptides Market Value by Application, (US$ Million) & (2024 VS 2031)
Table 3. Global Bioactive Proteins and Peptides Production Capacity (Tons) by Manufacturers in 2024
Table 4. Global Bioactive Proteins and Peptides Production by Manufacturers (2020-2025) & (Tons)
Table 5. Global Bioactive Proteins and Peptides Production Market Share by Manufacturers (2020-2025)
Table 6. Global Bioactive Proteins and Peptides Production Value by Manufacturers (2020-2025) & (US$ Million)
Table 7. Global Bioactive Proteins and Peptides Production Value Share by Manufacturers (2020-2025)
Table 8. Global Key Players of Bioactive Proteins and Peptides, Industry Ranking, 2023 VS 2024
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Production Value in Bioactive Proteins and Peptides as of 2024)
Table 10. Global Market Bioactive Proteins and Peptides Average Price by Manufacturers (US$/Ton) & (2020-2025)
Table 11. Global Key Manufacturers of Bioactive Proteins and Peptides, Manufacturing Base Distribution and Headquarters
Table 12. Global Key Manufacturers of Bioactive Proteins and Peptides, Product Offered and Application
Table 13. Global Key Manufacturers of Bioactive Proteins and Peptides, Date of Enter into This Industry
Table 14. Global Bioactive Proteins and Peptides Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Bioactive Proteins and Peptides Production Value by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 17. Global Bioactive Proteins and Peptides Production Value (US$ Million) by Region (2020-2025)
Table 18. Global Bioactive Proteins and Peptides Production Value Market Share by Region (2020-2025)
Table 19. Global Bioactive Proteins and Peptides Production Value (US$ Million) Forecast by Region (2026-2031)
Table 20. Global Bioactive Proteins and Peptides Production Value Market Share Forecast by Region (2026-2031)
Table 21. Global Bioactive Proteins and Peptides Production Comparison by Region: 2020 VS 2024 VS 2031 (Tons)
Table 22. Global Bioactive Proteins and Peptides Production (Tons) by Region (2020-2025)
Table 23. Global Bioactive Proteins and Peptides Production Market Share by Region (2020-2025)
Table 24. Global Bioactive Proteins and Peptides Production (Tons) Forecast by Region (2026-2031)
Table 25. Global Bioactive Proteins and Peptides Production Market Share Forecast by Region (2026-2031)
Table 26. Global Bioactive Proteins and Peptides Market Average Price (US$/Ton) by Region (2020-2025)
Table 27. Global Bioactive Proteins and Peptides Market Average Price (US$/Ton) by Region (2026-2031)
Table 28. Global Bioactive Proteins and Peptides Consumption Growth Rate by Region: 2020 VS 2024 VS 2031 (Tons)
Table 29. Global Bioactive Proteins and Peptides Consumption by Region (2020-2025) & (Tons)
Table 30. Global Bioactive Proteins and Peptides Consumption Market Share by Region (2020-2025)
Table 31. Global Bioactive Proteins and Peptides Forecasted Consumption by Region (2026-2031) & (Tons)
Table 32. Global Bioactive Proteins and Peptides Forecasted Consumption Market Share by Region (2026-2031)
Table 33. North America Bioactive Proteins and Peptides Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (Tons)
Table 34. North America Bioactive Proteins and Peptides Consumption by Country (2020-2025) & (Tons)
Table 35. North America Bioactive Proteins and Peptides Consumption by Country (2026-2031) & (Tons)
Table 36. Europe Bioactive Proteins and Peptides Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (Tons)
Table 37. Europe Bioactive Proteins and Peptides Consumption by Country (2020-2025) & (Tons)
Table 38. Europe Bioactive Proteins and Peptides Consumption by Country (2026-2031) & (Tons)
Table 39. Asia Pacific Bioactive Proteins and Peptides Consumption Growth Rate by Region: 2020 VS 2024 VS 2031 (Tons)
Table 40. Asia Pacific Bioactive Proteins and Peptides Consumption by Region (2020-2025) & (Tons)
Table 41. Asia Pacific Bioactive Proteins and Peptides Consumption by Region (2026-2031) & (Tons)
Table 42. Latin America, Middle East & Africa Bioactive Proteins and Peptides Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (Tons)
Table 43. Latin America, Middle East & Africa Bioactive Proteins and Peptides Consumption by Country (2020-2025) & (Tons)
Table 44. Latin America, Middle East & Africa Bioactive Proteins and Peptides Consumption by Country (2026-2031) & (Tons)
Table 45. Global Bioactive Proteins and Peptides Production (Tons) by Type (2020-2025)
Table 46. Global Bioactive Proteins and Peptides Production (Tons) by Type (2026-2031)
Table 47. Global Bioactive Proteins and Peptides Production Market Share by Type (2020-2025)
Table 48. Global Bioactive Proteins and Peptides Production Market Share by Type (2026-2031)
Table 49. Global Bioactive Proteins and Peptides Production Value (US$ Million) by Type (2020-2025)
Table 50. Global Bioactive Proteins and Peptides Production Value (US$ Million) by Type (2026-2031)
Table 51. Global Bioactive Proteins and Peptides Production Value Market Share by Type (2020-2025)
Table 52. Global Bioactive Proteins and Peptides Production Value Market Share by Type (2026-2031)
Table 53. Global Bioactive Proteins and Peptides Price (US$/Ton) by Type (2020-2025)
Table 54. Global Bioactive Proteins and Peptides Price (US$/Ton) by Type (2026-2031)
Table 55. Global Bioactive Proteins and Peptides Production (Tons) by Application (2020-2025)
Table 56. Global Bioactive Proteins and Peptides Production (Tons) by Application (2026-2031)
Table 57. Global Bioactive Proteins and Peptides Production Market Share by Application (2020-2025)
Table 58. Global Bioactive Proteins and Peptides Production Market Share by Application (2026-2031)
Table 59. Global Bioactive Proteins and Peptides Production Value (US$ Million) by Application (2020-2025)
Table 60. Global Bioactive Proteins and Peptides Production Value (US$ Million) by Application (2026-2031)
Table 61. Global Bioactive Proteins and Peptides Production Value Market Share by Application (2020-2025)
Table 62. Global Bioactive Proteins and Peptides Production Value Market Share by Application (2026-2031)
Table 63. Global Bioactive Proteins and Peptides Price (US$/Ton) by Application (2020-2025)
Table 64. Global Bioactive Proteins and Peptides Price (US$/Ton) by Application (2026-2031)
Table 65. Nuritas Bioactive Proteins and Peptides Company Information
Table 66. Nuritas Bioactive Proteins and Peptides Specification and Application
Table 67. Nuritas Bioactive Proteins and Peptides Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 68. Nuritas Main Business and Markets Served
Table 69. Nuritas Recent Developments/Updates
Table 70. Gelita Bioactive Proteins and Peptides Company Information
Table 71. Gelita Bioactive Proteins and Peptides Specification and Application
Table 72. Gelita Bioactive Proteins and Peptides Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 73. Gelita Main Business and Markets Served
Table 74. Gelita Recent Developments/Updates
Table 75. Arta Peptidion Bioactive Proteins and Peptides Company Information
Table 76. Arta Peptidion Bioactive Proteins and Peptides Specification and Application
Table 77. Arta Peptidion Bioactive Proteins and Peptides Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 78. Arta Peptidion Main Business and Markets Served
Table 79. Arta Peptidion Recent Developments/Updates
Table 80. Seagarden Bioactive Proteins and Peptides Company Information
Table 81. Seagarden Bioactive Proteins and Peptides Specification and Application
Table 82. Seagarden Bioactive Proteins and Peptides Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 83. Seagarden Main Business and Markets Served
Table 84. Seagarden Recent Developments/Updates
Table 85. Phermpep Bioactive Proteins and Peptides Company Information
Table 86. Phermpep Bioactive Proteins and Peptides Specification and Application
Table 87. Phermpep Bioactive Proteins and Peptides Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 88. Phermpep Main Business and Markets Served
Table 89. Phermpep Recent Developments/Updates
Table 90. Hubei Reborn Biotech Bioactive Proteins and Peptides Company Information
Table 91. Hubei Reborn Biotech Bioactive Proteins and Peptides Specification and Application
Table 92. Hubei Reborn Biotech Bioactive Proteins and Peptides Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 93. Hubei Reborn Biotech Main Business and Markets Served
Table 94. Hubei Reborn Biotech Recent Developments/Updates
Table 95. Tus-Harvest Biotech Bioactive Proteins and Peptides Company Information
Table 96. Tus-Harvest Biotech Bioactive Proteins and Peptides Specification and Application
Table 97. Tus-Harvest Biotech Bioactive Proteins and Peptides Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 98. Tus-Harvest Biotech Main Business and Markets Served
Table 99. Tus-Harvest Biotech Recent Developments/Updates
Table 100. Zhejiang Huitai Life Health Technology Bioactive Proteins and Peptides Company Information
Table 101. Zhejiang Huitai Life Health Technology Bioactive Proteins and Peptides Specification and Application
Table 102. Zhejiang Huitai Life Health Technology Bioactive Proteins and Peptides Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 103. Zhejiang Huitai Life Health Technology Main Business and Markets Served
Table 104. Zhejiang Huitai Life Health Technology Recent Developments/Updates
Table 105. Beijing Renxinruoshui Biotech Bioactive Proteins and Peptides Company Information
Table 106. Beijing Renxinruoshui Biotech Bioactive Proteins and Peptides Specification and Application
Table 107. Beijing Renxinruoshui Biotech Bioactive Proteins and Peptides Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 108. Beijing Renxinruoshui Biotech Main Business and Markets Served
Table 109. Beijing Renxinruoshui Biotech Recent Developments/Updates
Table 110. Key Raw Materials Lists
Table 111. Raw Materials Key Suppliers Lists
Table 112. Bioactive Proteins and Peptides Distributors List
Table 113. Bioactive Proteins and Peptides Customers List
Table 114. Bioactive Proteins and Peptides Market Trends
Table 115. Bioactive Proteins and Peptides Market Drivers
Table 116. Bioactive Proteins and Peptides Market Challenges
Table 117. Bioactive Proteins and Peptides Market Restraints
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
Table 121. Authors List of This Report
List of Figures
Figure 1. Product Picture of Bioactive Proteins and Peptides
Figure 2. Global Bioactive Proteins and Peptides Market Value by Type, (US$ Million) & (2020-2031)
Figure 3. Global Bioactive Proteins and Peptides Market Share by Type: 2024 VS 2031
Figure 4. Plant Source Product Picture
Figure 5. Animal Source Product Picture
Figure 6. Global Bioactive Proteins and Peptides Market Value by Application, (US$ Million) & (2020-2031)
Figure 7. Global Bioactive Proteins and Peptides Market Share by Application: 2024 VS 2031
Figure 8. Food
Figure 9. Pharmaceutical
Figure 10. Cosmetic
Figure 11. Others
Figure 12. Global Bioactive Proteins and Peptides Production Value (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Bioactive Proteins and Peptides Production Value (US$ Million) & (2020-2031)
Figure 14. Global Bioactive Proteins and Peptides Production Capacity (Tons) & (2020-2031)
Figure 15. Global Bioactive Proteins and Peptides Production (Tons) & (2020-2031)
Figure 16. Global Bioactive Proteins and Peptides Average Price (US$/Ton) & (2020-2031)
Figure 17. Bioactive Proteins and Peptides Report Years Considered
Figure 18. Bioactive Proteins and Peptides Production Share by Manufacturers in 2024
Figure 19. Global Bioactive Proteins and Peptides Production Value Share by Manufacturers (2024)
Figure 20. Bioactive Proteins and Peptides Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 21. The Global 5 and 10 Largest Players: Market Share by Bioactive Proteins and Peptides Revenue in 2024
Figure 22. Global Bioactive Proteins and Peptides Production Value by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 23. Global Bioactive Proteins and Peptides Production Value Market Share by Region: 2020 VS 2024 VS 2031
Figure 24. Global Bioactive Proteins and Peptides Production Comparison by Region: 2020 VS 2024 VS 2031 (Tons)
Figure 25. Global Bioactive Proteins and Peptides Production Market Share by Region: 2020 VS 2024 VS 2031
Figure 26. North America Bioactive Proteins and Peptides Production Value (US$ Million) Growth Rate (2020-2031)
Figure 27. Europe Bioactive Proteins and Peptides Production Value (US$ Million) Growth Rate (2020-2031)
Figure 28. China Bioactive Proteins and Peptides Production Value (US$ Million) Growth Rate (2020-2031)
Figure 29. Japan Bioactive Proteins and Peptides Production Value (US$ Million) Growth Rate (2020-2031)
Figure 30. Global Bioactive Proteins and Peptides Consumption by Region: 2020 VS 2024 VS 2031 (Tons)
Figure 31. Global Bioactive Proteins and Peptides Consumption Market Share by Region: 2020 VS 2024 VS 2031
Figure 32. North America Bioactive Proteins and Peptides Consumption and Growth Rate (2020-2031) & (Tons)
Figure 33. North America Bioactive Proteins and Peptides Consumption Market Share by Country (2020-2031)
Figure 34. U.S. Bioactive Proteins and Peptides Consumption and Growth Rate (2020-2031) & (Tons)
Figure 35. Canada Bioactive Proteins and Peptides Consumption and Growth Rate (2020-2031) & (Tons)
Figure 36. Europe Bioactive Proteins and Peptides Consumption and Growth Rate (2020-2031) & (Tons)
Figure 37. Europe Bioactive Proteins and Peptides Consumption Market Share by Country (2020-2031)
Figure 38. Germany Bioactive Proteins and Peptides Consumption and Growth Rate (2020-2031) & (Tons)
Figure 39. France Bioactive Proteins and Peptides Consumption and Growth Rate (2020-2031) & (Tons)
Figure 40. U.K. Bioactive Proteins and Peptides Consumption and Growth Rate (2020-2031) & (Tons)
Figure 41. Italy Bioactive Proteins and Peptides Consumption and Growth Rate (2020-2031) & (Tons)
Figure 42. Russia Bioactive Proteins and Peptides Consumption and Growth Rate (2020-2031) & (Tons)
Figure 43. Asia Pacific Bioactive Proteins and Peptides Consumption and Growth Rate (2020-2031) & (Tons)
Figure 44. Asia Pacific Bioactive Proteins and Peptides Consumption Market Share by Region (2020-2031)
Figure 45. China Bioactive Proteins and Peptides Consumption and Growth Rate (2020-2031) & (Tons)
Figure 46. Japan Bioactive Proteins and Peptides Consumption and Growth Rate (2020-2031) & (Tons)
Figure 47. South Korea Bioactive Proteins and Peptides Consumption and Growth Rate (2020-2031) & (Tons)
Figure 48. China Taiwan Bioactive Proteins and Peptides Consumption and Growth Rate (2020-2031) & (Tons)
Figure 49. Southeast Asia Bioactive Proteins and Peptides Consumption and Growth Rate (2020-2031) & (Tons)
Figure 50. India Bioactive Proteins and Peptides Consumption and Growth Rate (2020-2031) & (Tons)
Figure 51. Latin America, Middle East & Africa Bioactive Proteins and Peptides Consumption and Growth Rate (2020-2031) & (Tons)
Figure 52. Latin America, Middle East & Africa Bioactive Proteins and Peptides Consumption Market Share by Country (2020-2031)
Figure 53. Mexico Bioactive Proteins and Peptides Consumption and Growth Rate (2020-2031) & (Tons)
Figure 54. Brazil Bioactive Proteins and Peptides Consumption and Growth Rate (2020-2031) & (Tons)
Figure 55. Turkey Bioactive Proteins and Peptides Consumption and Growth Rate (2020-2031) & (Tons)
Figure 56. GCC Countries Bioactive Proteins and Peptides Consumption and Growth Rate (2020-2031) & (Tons)
Figure 57. Global Production Market Share of Bioactive Proteins and Peptides by Type (2020-2031)
Figure 58. Global Production Value Market Share of Bioactive Proteins and Peptides by Type (2020-2031)
Figure 59. Global Bioactive Proteins and Peptides Price (US$/Ton) by Type (2020-2031)
Figure 60. Global Production Market Share of Bioactive Proteins and Peptides by Application (2020-2031)
Figure 61. Global Production Value Market Share of Bioactive Proteins and Peptides by Application (2020-2031)
Figure 62. Global Bioactive Proteins and Peptides Price (US$/Ton) by Application (2020-2031)
Figure 63. Bioactive Proteins and Peptides Value Chain
Figure 64. Channels of Distribution (Direct Vs Distribution)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Chemicals Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
